Sort   by:  
 Page size 
UnknownConcomitant Drugs Prognostic Score in Patients With Metastatic Renal Cell Carcinoma Receiving Ipilimumab and Nivolumab in the Compassionate Use Program in Italy: Brief Communication.
Not available
S-EPMC10561686 | biostudies-literature
UnknownThe prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study.
Not available
S-EPMC9524042 | biostudies-literature
UnknownSodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of Meet-Uro 15 study.
Not available
S-EPMC11257879 | biostudies-literature
UnknownLong-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study.
Not available
S-EPMC11219688 | biostudies-literature
UnknownUsing peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis.
Not available
S-EPMC10583024 | biostudies-literature
UnknownMiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints.
Not available
S-EPMC7840941 | biostudies-literature
Unknownβ-Secretase1 biological markers for Alzheimer's disease: state-of-art of validation and qualification.
Not available
S-EPMC7566058 | biostudies-literature
UnknownInflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study).
Not available
S-EPMC8135208 | biostudies-literature
UnknownAge and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study.
Not available
S-EPMC7663867 | biostudies-literature
Sort   by:  
 Page size